Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-21Clinical Trial Update: Impact of Atorvastatin on Prostate Cancer Progression During ADT [Phase 3]
Phase 3 trial investigating the impact of atorvastatin on progression of metastatic or recurrent prostate cancer during androgen deprivation…
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Metformin Prostate Cancer Adjuvant Trial [Phase 2]
Phase 2 clinical trial update on metformin as adjuvant therapy in prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer [Phase 1]
Phase 1 trial evaluating epitope-enhanced TARP peptide vaccines with TARP peptide-pulsed dendritic cells in stage D0 prostate cancer; comple…
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Improving Urinary Continence and Quality of Life in Prostate Cancer Patients [NA]
Clinical trial investigating urinary continence improvements and quality of life in prostate cancer patients has completed with results post…
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer [Phase 3]
This Phase 3 trial compares radiation therapy with versus without androgen-deprivation therapy in men with prostate cancer, with results pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2022-09-29Clinical Trial Update: A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer [Phase 2]
Phase 2 biomarker study evaluating standard-of-care Radium-223 chloride in metastatic castration-resistant prostate cancer; study completed …
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature [Phase 2]
Phase 2 clinical trial update evaluating nivolumab plus ipilimumab in prostate cancer with an immunogenic signature.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Vaccine Therapy in Curative Resected Prostate Cancer Patients [Phase 1, Phase 2]
A phase 1/2 clinical trial update investigating a vaccine therapy in curatively resected prostate cancer patients; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer [Phase 2]
Phase 2 trial evaluating genistein supplementation to mitigate cardiometabolic dysfunction in patients undergoing androgen deprivation thera…
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 [Phase 2]
Phase 2 trial update on long-term TARP peptide autologous dendritic cell vaccination for prostate cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer [Phase 2]
Phase 2 trial update evaluating neoadjuvant androgen deprivation therapy with abiraterone, with or without apalutamide, for high-risk prosta…
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer [Phase 2]
Phase II single-arm pilot study of the Chk1/2 inhibitor LY2606368 in BRCA1/2 mutation-associated breast or ovarian cancer, triple negative b…
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer [Phase 3]
Phase III SWOG trial comparing androgen deprivation therapy plus TAK-700 (Orteronel) versus ADT plus bicalutamide in metastatic prostate can…
-
CLINICAL_TRIALS withdrawal · 2022-09-06Clinical Trial Update: Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy [Phase 2, Phase 3]
A clinical trial investigating an opioid-free pain control regimen following robotic radical prostatectomy has been withdrawn.
-
FDA approval · 2022-09-02FDA Approved: ABIRATERONE ACETATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for abiraterone acetate (ABIRATERONE) from Amneal Pharmaceuticals NY LLC, authorizing changes to…
-
FDA approval · 2022-08-31FDA Approved: ABIRATERONE ACETATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for abiraterone acetate from Mylan Pharmaceuticals Inc., enabling a generic version of the cance…
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC [Phase 1, Phase 2]
Phase 1/2 trial evaluating LEE011 (ribociclib) in combination with docetaxel and prednisone for metastatic castration-resistant prostate can…
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate Cancer [Phase 2]
A Phase 2 trial comparing radical radiotherapy to prostate-only versus prostate and pelvic lymph nodes in intermediate and high-risk prostat…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma [NA]
Completed clinical trial evaluating fluciclovine-PET/CT for detecting bone metastases in prostate adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients [Phase 2, Phase 3]
Phase 2/3 clinical trial update comparing 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT imaging in the same group of prostate cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating docetaxel with or without ascorbic acid in metastatic, hormone-resistant prostate cancer has terminated; results po…
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: A Study of Definitive Therapy to Treat Prostate Cancer [Phase 2]
Phase 2 trial update on definitive therapy for prostate cancer with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen Therapy [Phase 2]
Phase 2 clinical trial update analyzing biomarkers in prostate cancer patients undergoing bipolar androgen therapy.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness [Phase 3]
Phase 3 trial evaluating early salvage therapy for biochemical relapse after radical prostatectomy in localized prostate cancer, exploring c…
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating enzalutamide with mifepristone in metastatic hormone-resistant prostate cancer completed with results posted in 2…